Endpoints News

Despite FDA’s crackdown, pharma is still spending millions on ads

Last fall, the FDA launched what it called an aggressive crackdown on pharma advertising, sending drugmakers thousands of letters demanding that they remove misleading consumer ads.

This report was first published by Endpoints News. To see the original version, click here

Last fall, the FDA launched what it called an aggressive crackdown on pharma advertising, sending drugmakers thousands of letters demanding that they remove misleading consumer ads.

Months later, the pharma industry is still spending hundreds of millions of dollars on ads.

您已阅读6%(362字),剩余94%(5915字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×